You are here

  • Home
  • Online First
  • Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab

Citation Tools

Article menu

other Versions

Original research
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kristeleit R, Mathews C, Redondo A, et al
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab
International Journal of Gynecologic Cancer Published Online First: 16 August 2022. doi: 10.1136/ijgc-2022-003492